Stocks

AbbVie ABBV

Health care sectorNYSE

What to see in AbbVie now

Is Wall Street adding or cutting?+106

4,210 13F filers hold it · +106 against the quarter before · shares held +2.7%

Holdings of 06/30
Are members of Congress buying or selling?2

2 members of Congress traded it in 90 days · 1 purchases · 1 sales

Reported 09/18
How much more do Koreans hold through ETFs?$94.6M

Koreans hold $94.6M more through 6 ETFs

Holdings of 06/30
Close
$261.94
09/30 close
Day change
−0.5%
vs previous close
Volume
126,056
−44.0% vs 30-day average
52-week range
$191.33$269.25
1-year return
+13.1%
vs the close a year ago
Market cap
$462.9B
1,767,117,285 shares · reported 07/27

Company

Exchange
NYSE
Industry
Pharmaceutical Preparations
Headquarters
North Chicago, Illinois
Fiscal year end
12/31
Next earnings
08/28, estimated
  • Koreans hold $94.6M more through 6 ETFsHoldings of 06/30

Price

$261.94Day −0.5%1 year +13.1%

26-week trading

Members of Congress reported 2 trades in AbbVie ABBV in the past 90 days (1 purchase, 1 sale).

Common questions

Which members of Congress traded AbbVie ABBV recently?
The latest reported trades: Rep. Pete Sessions, full sale on 09/14 (reported 09/18), Sen. Alan Armstrong, purchase on 03/27 (reported 07/21), Rep. Josh Gottheimer, full sale on 05/05 (reported 06/03), Rep. Julie Johnson, full sale on 25/12/18 (reported 01/15) and Rep. Julia Letlow, full sale on 25/12/08 (reported 01/13).